Aardvark Therapeutics (AARD) Stock Chart & Stock Price History $10.01 -1.11 (-9.98%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Aardvark Therapeutics Stock Price Performance The Aardvark Therapeutics (AARD) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 30.68%, reflecting recent market activity. As of the latest close, Aardvark Therapeutics traded at $11.12 with a market cap of $241.26 million and volume of 23,747 shares. Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.21%1 Month Performance+30.68%3 Month Performance-28.60% AARD Stock Chart for Thursday, May, 22, 2025 AARD Chart by TradingView Aardvark Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$11.00$11.12+1.09%$11.50$10.4023,747 shs$241.26 million05/20/2025$10.43$11.00+5.47%$11.00$10.4219,980 shs$238.66 million05/19/2025$9.89$10.43+5.46%$10.50$9.7044,444 shs$226.29 million05/16/2025$9.09$9.89+8.80%$10.01$8.7519,150 shs$214.57 million05/15/2025$8.74$9.09+4.00%$10.55$8.7443,653 shs$197.22 million05/14/2025$10.14$8.74-13.81%$10.26$8.50146,968 shs$189.62 million05/13/2025$10.97$10.14-7.57%$11.38$10.0052,328 shs$220.00 million05/12/2025$10.42$10.97+5.28%$11.03$10.1519,641 shs$238.01 million05/09/2025$10.80$10.42-3.52%$12.89$10.00215,243 shs$226.07 million05/08/2025$10.63$10.80+1.60%$11.24$10.4817,195 shs$234.32 million Get the Latest News and Ratings for AARD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$10.45$10.63+1.72%$10.77$10.3115,055 shs$230.63 million05/06/2025$10.54$10.45-0.85%$11.68$10.4035,446 shs$226.72 million05/05/2025$12.86$10.54-18.04%$13.25$10.4260,775 shs$228.68 million05/02/2025$11.33$12.86+13.50%$13.56$11.10161,986 shs$279.01 million05/01/2025$11.11$11.33+1.98%$11.57$10.46171,760 shs$245.82 million04/30/2025$11.43$11.11-2.80%$11.40$9.3668,559 shs$241.04 million04/29/2025$10.12$11.43+12.94%$11.44$10.3378,263 shs$247.99 million04/28/2025$7.93$10.12+27.62%$10.29$8.0152,058 shs$219.56 million04/25/2025$8.22$7.93-3.53%$8.12$7.2744,223 shs$172.05 million04/24/2025$8.52$8.22-3.52%$8.55$7.3651,484 shs$178.34 million04/23/2025$7.66$8.52+11.23%$8.54$7.7793,383 shs$184.85 million04/22/2025$7.12$7.66+7.58%$7.88$6.9382,143 shs$166.19 million04/21/2025$7.00$7.12+1.71%$7.34$6.7525,885 shs$154.48 million Related Companies LENZ Stock Price Chart SNDX Stock Price Chart CVAC Stock Price Chart NUVB Stock Price Chart PRAX Stock Price Chart XERS Stock Price Chart QURE Stock Price Chart NRIX Stock Price Chart RCKT Stock Price Chart AVXL Stock Price Chart Receive AARD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aardvark Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AARD) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aardvark Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aardvark Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AARD Stock Free AARD Stock Alerts